Subcutaneous immunoglobulin in primary immunodeficiency – impact of training and infusion characteristics on patient-reported outcomes | BMC Immunology | Full Text

Subcutaneous immunoglobulin in primary immunodeficiency – impact of training and infusion characteristics on patient-reported outcomes | BMC Immunology | Full Text

Subcutaneous immunoglobulin in primary immunodeficiency – impact of training and infusion characteristics on patient-reported outcomes

Subcutaneous immunoglobulin (SCIG) is increasingly utilized in primary immunodeficiency (PI). Understanding factors associated with treatment experience and satisfaction can optimize patient outcomes. We analy...

Authors:R. Mallick, T. Henderson, B. J. Lahue, A. Kafal, P. Bassett and C. Scalchunes

Citation:BMC Immunology 2020 21:47

Content type:Research article

 

Published on: 10 August 2020

• ViewFull Text
 
• ViewPDF